Kenia Arisbe Moreno Amador
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kenia Arisbe Moreno Amador has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Rodríguez-Padilla
Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Mexico
2 shared publications - Moisés Armides Franco-Molina
Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, NL, Mexico
2 shared publications - Paola Leonor García Coronado
Laboratorio de Inmunología y Virología, Unidad C, Facultado de Ciencias Biologicas, Universidad Autonoma de Nuevo León, Ave. Universidad S/N, Cd. Universitaria, San Nicolás de los Garza 66445, Mexico
2 shared publications - Ashanti Concepción Uscanga-Palomeque
Laboratorio de Inmunología y Virología, Departamento de Microbiología e Inmunología, Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, San Nicolás de los Garza
1 shared publication - Beatriz Elena Castro-Valenzuela
Facultad de Zootecnia y Ecología, Universidad Autónoma de Chihuahua, Chihuahua 31453, Mexico
1 shared publication - David Reding Hernández
Laboratorio de Inmunología y Virología, Unidad C, Facultado de Ciencias Biologicas, Universidad Autonoma de Nuevo León, Ave. Universidad S/N, Cd. Universitaria, San Nicolás de los Garza 66445, Mexico
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (11) , 1166
Trace Minerals as Immune Nutritional Adjuvants in Beef Cattle: Metabolic Pathways, Nutritional Immunity and Administration Strategies
Trace minerals are essential cofactors for antioxidant enzymes and immune signaling, yet their status is frequently compromised during stress (weaning, feedlot arrival) due to pre-existing dietary deficiencies, transient reductions in nutrient intake, and acute-phase inflammatory redistribution, increasing bovine respiratory disease (BRD) risk. This critical narrative review integrates the metabolic and immunological pathways of these minerals, highlighting the host’s “nutritional immunity” during acute-phase responses. It contrasts continuous, intake-dependent oral supplementation with rapid, transient injectable routes. Furthermore, it evaluates injectable chemical forms: ethylenediaminetetraacetic acid (EDTA) chelates, upon which most evidence rests, versus gluconates, clarifying that any metabolic advantages of the latter remain strictly hypothetical in the absence of direct comparative cattle trials. While injectables rapidly elevate systemic mineral concentrations, inferences drawn from the synthesized body of evidence indicate that productive and health benefits are inconsistent, primarily favoring high-risk or deficient cattle. Rather than an experimentally validated protocol, the authors propose a theoretical decision model that positions injectable mineral as a targeted “preload” before or during immunological challenges, while oral supplementation serves as the indispensable baseline to maintain reserves. To refine this theoretical approach, further research is needed to address critical knowledge gaps, particularly through efficacy trials that simultaneously evaluate baseline mineral status, immune response, disease incidence, and production performance across different injectable formulations.
- 30 October 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (11) , 1166
Open AccessTrace Minerals as Immune Nutritional Adjuvants in Beef Cattle: Metabolic Pathways, Nutritional Immunity and Administration Strategies
Trace minerals are essential cofactors for antioxidant enzymes and immune signaling, yet their status is frequently compromised during stress (weaning, feedlot arrival) due to pre-existing dietary deficiencies, transient reductions in nutrient intake, and acute-phase inflammatory redistribution, increasing bovine respiratory disease (BRD) risk. This critical narrative review integrates the metabolic and immunological pathways of these minerals, highlighting the host’s “nutritional immunity” during acute-phase responses. It contrasts continuous, intake-dependent oral supplementation with rapid, transient injectable routes. Furthermore, it evaluates injectable chemical forms: ethylenediaminetetraacetic acid (EDTA) chelates, upon which most evidence rests, versus gluconates, clarifying that any metabolic advantages of the latter remain strictly hypothetical in the absence of direct comparative cattle trials. While injectables rapidly elevate systemic mineral concentrations, inferences drawn from the synthesized body of evidence indicate that productive and health benefits are inconsistent, primarily favoring high-risk or deficient cattle. Rather than an experimentally validated protocol, the authors propose a theoretical decision model that positions injectable mineral as a targeted “preload” before or during immunological challenges, while oral supplementation serves as the indispensable baseline to maintain reserves. To refine this theoretical approach, further research is needed to address critical knowledge gaps, particularly through efficacy trials that simultaneously evaluate baseline mineral status, immune response, disease incidence, and production performance across different injectable formulations.
- Open Access
- 2 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8432
β-D-Glucose-Reduced Silver Nanoparticles Remodel the Tumor Microenvironment in a Murine Model of Triple-Negative Breast Cancer
Breast cancer is the most diagnosed type of cancer worldwide and the second cause of death in women. Triple-negative breast cancer (TNBC) is the most aggressive, and due to the lack of specific targets, it is considered the most challenging subtype to treat and the subtype with the worst prognosis. The present study aims to determine the antitumor effect of beta-D-glucose-reduced silver nanoparticles (AgNPs-G) in a murine model of TNBC, as well as to study its effect on the tumor microenvironment. In an airbag model with 4T1 tumor cell implantation, the administration of AgNPs-G or doxorubicin showed antitumoral activity. Using immunohistochemistry it was demonstrated that treatment with AgNPs-G decreased the expression of PCNA, IDO, and GAL-3 and increased the expression of Caspase-3. In the tumor microenvironment, the treatment increased the percentage of memory T cells and innate effector cells and decreased CD4+ cells and regulatory T cells. There was also an increase in the levels of TNF-α, IFN-γ, and IL-6, while TNF-α was increased in serum. In conclusion, we suggest that AgNPs-G treatment has an antitumor effect that is demonstrated by its ability to remodel the tumor microenvironment in mice with TNBC.
- 2 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8432
Open Accessβ-D-Glucose-Reduced Silver Nanoparticles Remodel the Tumor Microenvironment in a Murine Model of Triple-Negative Breast Cancer
Breast cancer is the most diagnosed type of cancer worldwide and the second cause of death in women. Triple-negative breast cancer (TNBC) is the most aggressive, and due to the lack of specific targets, it is considered the most challenging subtype to treat and the subtype with the worst prognosis. The present study aims to determine the antitumor effect of beta-D-glucose-reduced silver nanoparticles (AgNPs-G) in a murine model of TNBC, as well as to study its effect on the tumor microenvironment. In an airbag model with 4T1 tumor cell implantation, the administration of AgNPs-G or doxorubicin showed antitumoral activity. Using immunohistochemistry it was demonstrated that treatment with AgNPs-G decreased the expression of PCNA, IDO, and GAL-3 and increased the expression of Caspase-3. In the tumor microenvironment, the treatment increased the percentage of memory T cells and innate effector cells and decreased CD4+ cells and regulatory T cells. There was also an increase in the levels of TNF-α, IFN-γ, and IL-6, while TNF-α was increased in serum. In conclusion, we suggest that AgNPs-G treatment has an antitumor effect that is demonstrated by its ability to remodel the tumor microenvironment in mice with TNBC.